Clinical Trial

Periodontal Regeneration With Hyaluronic Acid or Enamel Matrix Derivatives

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 27, 2023 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To date, the quest for ideal biological inductors for periodontal regeneration is still ongoing, especially when facing non-containing defect anatomies. The primary aim of this study is to evaluate the clinical and radiographic performance of a bone graft combined with either enamel matrix derivatives or hyaluronic acid for periodontal regeneration of non-containing intrabony defects in terms of clinical attachment gain (primary outcome) and other secondary outcomes (probing pocket depth reduction, radiographic bone fill). Moreover, this study aims to compare early wound healing and patient-reported outcome measures.
Trial Details
NCT Number NCT06105112
Lead Sponsor University of Turin, Italy
Conditions Periodontitis
Enrollment 60 participants
Start Date 2023-10-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2023-10-27